The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Endosomal escape pathways for delivery of biologicals
Open accessAbstract
Despite continuous improvements in delivery systems, the development of methods for efficient and specific delivery of targeted therapeutic agents still remains an issue in biological treatments such as protein and gene therapy. The endocytic pathway is the major uptake mechanism of cells and any biological agents, such as DNA, siRNA and proteins. These agents become entrapped in endosomes and are degraded by specific enzymes in the lysosome. Thus, a limiting step in achieving an effective biological based therapy is to facilitate the endosomal escape and ensure cytosolic delivery of the therapeutics. Bacteria and viruses are pathogens which use different mechanisms to penetrate the membranes of their target cells and escape the endosomal pathway. Different mechanisms such as pore formation in the endosomal membrane, pH-buffering effect of protonable groups and fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal escape. Several viral and bacterial proteins have been identified that are involved in this process. In addition, chemical agents and photochemical methods to rupture the endosomal membrane have been described. New synthetic biomimetic peptides and polymers with high efficacy in facilitating the endosomal escape, low pathogenicity and toxicity have been developed. Each strategy has different characteristics and challenges for designing the best agents and techniques to facilitate the endosomal escape are ongoing. In this review, several mechanisms and agents which are involved in endosomal escape are introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,605
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,045
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
The actions of melittin on membranes
Dempsey, C. E. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90006-x · Cited by 852
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P. C., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Cited by
Sorted by citations
Items 401–500 of 1,000
Jiang, L., Ding, L., & Liu, G. (2023) · Theranostics · doi:10.7150/thno.82790 · Cited by 65
Strategies for the Nuclear Delivery of Metal Complexes to Cancer Cells
Huynh, M., Vinck, R., Gibert, B., & Gasser, G. (2024) · Advanced Materials · doi:10.1002/adma.202311437 · Cited by 59
Sengupta, A., Kelly, S. C., Dwivedi, N., Thadhani, N. N., & Prausnitz, M. R. (2014) · ACS Nano · doi:10.1021/nn500100x · Cited by 59
A Programmable Sensor to Probe the Internalization of Proteins and Nanoparticles in Live Cells
Liu, H., & Johnston, A. P. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201301243 · Cited by 59
Kamaruzzaman, N. F., Chong, S. Q. Y., Edmondson-Brown, K. M., Ntow‐Boahene, W., Bardiau, M., & Good, L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01518 · Cited by 59
siRNA in ovarian cancer – Delivery strategies and targets for therapy
van den Brand, D., Mertens, V., Massuger, L. F. A. G., & Brock, R. E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.012 · Cited by 60
Díaz‐Perlas, C., Oller‐Salvia, B., Sánchez‐Navarro, M., Teixidò, M., & Giralt, E. (2018) · Chemical Science · doi:10.1039/c8sc02415d · Cited by 59
Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
Delehedde, C., Even, L., Midoux, P., Pichon, C., & Perche, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070945 · Cited by 60
Joubert, F., Munson, M. J., Sabirsh, A., England, R., Hemmerling, M., Alexander, C., & Ashford, M. B. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.011 · Cited by 58
Nanobiomaterial vectors for improving gene editing and gene therapy
Hu, S. W., Ding, T., Tang, H., Guo, H., Cui, W., & Shu, Y. (2023) · Materials Today · doi:10.1016/j.mattod.2023.04.011 · Cited by 58
Pei, Z., Lei, H., Wu, J., Tang, W., Wei, K., Wang, L., Gong, F., Yang, N., Liu, L., Yang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c04767 · Cited by 58
Intracellular probes for imaging oxygen concentration: how good are they?
Dmitriev, R. I., & Papkovsky, D. B. (2015) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/3/3/034001 · Cited by 62
Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells
Imani, R., Shao, W., Taherkhani, S., Emami, S. H., Prakash, S., & Faghihi, S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.015 · Cited by 58
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies
Fuchs, H., Niesler, N., Trautner, A., Sama, S., Jerz, G., Panjideh, H., & Weng, A. (2017) · Biomedicines · doi:10.3390/biomedicines5020014 · Cited by 59
From Endocytosis to Nonendocytosis: The Emerging Era of Gene Delivery
Zhou, J. J., Shao, Z., Liu, J., Duan, Q., Wang, X., Li, J., & Yang, H. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01131 · Cited by 59
Layek, B., & Singh, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.052 · Cited by 57
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Uzhytchak, M., Smolková, B., Lunová, M., Frtús, A., Jirsa, M., Dejneka, A., & Lunov, O. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114828 · Cited by 61
Aly, S., El-Kamel, A. H., Sheta, E., & El-Habashy, S. E. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123163 · Cited by 57
Li, Y., Sun, H., Cao, D. S., Guo, Y., Wu, D., Yang, M., Wang, H., Shao, X., Li, Y., & Liang, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s497510 · Cited by 60
Higuchi, Y., Wu, C., Chang, K., Irie, K., Kawakami, S., Yamashita, F., & Hashida, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.076 · Cited by 57
Gan, Q., Lu, X., Dong, W., Yuan, Y., Qian, J., Li, Y., Shi, J., & Liu, C. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32020g · Cited by 57
Understanding nano-bio interactions to improve nanocarriers for drug delivery
Pearson, R. M., Hsu, H.-J., Bugno, J., & Hong, S. (2014) · MRS Bulletin · doi:10.1557/mrs.2014.9 · Cited by 57
Lin, G., Zhang, Y., Zhang, L., Wang, J., Tian, Y., Cai, W., Tang, S., Chu, C., Zhou, J., Mi, P., et al. (2020) · Nano Research · doi:10.1007/s12274-019-2606-2 · Cited by 57
Herranz‐Blanco, B., Shahbazi, M., Correia, A. M. R., Balasubramanian, V., Kohout, T., Hirvonen, J. J., & Santos, H. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600160 · Cited by 57
Endosomal escape for cell-targeted proteins. Going out after going in
Voltà‐Durán, E., Parladé, E., Serna, N., Villaverde, A., Vázquez, E., & Unzueta, U. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108103 · Cited by 56
Su, C., Liu, S., Sun, M., Yu, Q., Li, C., Graham, R. I., Wang, X., Wang, X., Xu, P., & Ren, G. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20151 · Cited by 56
Wagenaar, T. R., Tolstykh, T., Shi, C., Jiang, L., Zhang, J., Li, Z., Yu, Q., Qu, H., Sun, F., Cao, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1367 · Cited by 54
Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity
Perche, F., Yi, Y., Hespel, L., Mi, P., Dirisala, A., Cabral, H., Miyata, K., & Kataoka, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.027 · Cited by 56
Peetla, C., Jin, S.-H., Weimer, J. M., Elegbede, A. I., & Labhasetwar, V. D. (2014) · Langmuir · doi:10.1021/la5015219 · Cited by 56
Heat shock proteins and cancer: How can nanomedicine be harnessed?
Sauvage, F., Messaoudi, S., Fattal, E., BARRATT, G. M., & Vergnaud, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.013 · Cited by 56
Dabaghian, M., Latifi, A. M., Tebianian, M., Najminejad, H., & Ebrahimi, S. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.072 · Cited by 56
Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
Wei, L., Zhao, Y., Hu, X., & Tang, L. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01174 · Cited by 57
Zhu, Y., Jia, H., Duan, Q., Liu, X., Yang, J., Liu, Y., & Wu, F. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09110 · Cited by 56
Potential therapies and diagnosis based on Golgi-targeted nano drug delivery systems
Zhang, M., Xu, N., Xu, W., Ling, G., & Zhang, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105861 · Cited by 54
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy
Karmacharya, P., Patil, B. R., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00569-9 · Cited by 54
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
Chen, C., Zhong, W., Du, S., Li, Y., Zeng, Y., Liu, K., Yang, J., Guan, X., & Han, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.013 · Cited by 56
Feng, S., Xie, X., Liu, J., Li, A., Wang, Q., Guo, D., Li, S., Li, Y., Wang, Z., Guo, T., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02139-z · Cited by 59
Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67
Wang, S., Hüttmann, G., Zhang, Z., Vogel, A., Birngruber, R., Tangutoori, S., Hasan, T. G., & Rahmanzadeh, R. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00260 · Cited by 54
Polymer nanocarriers for MicroRNA delivery
Kapadia, C. H., Luo, B., Dang, M. N., Irvin-Choy, N. S., Valcourt, D. M., & Day, E. S. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48651 · Cited by 60
Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies
Pereira‐Silva, M., Jarak, I., Alvarez‐Lorenzo, C., Concheiro, Á., Paiva‐Santos, A. C., Veiga, F., & Figueiras, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.041 · Cited by 56
Tanaka, K., Okuda, T., Kasahara, Y., & Obika, S. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.016 · Cited by 54
Niosomal delivery of simvastatin to MDA-MB-231 cancer cells
Akbarzadeh, I., Poor, A. S., Yaghmaei, S., Norouzian, D., Noorbazargan, H., Saffar, S., Cohan, R. A., & Bakhshandeh, H. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1810269 · Cited by 53
Zhuang, C., Kang, M., & Lee, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.018 · Cited by 54
Lehn, R. C. V., & Alexander‐Katz, A. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506239p · Cited by 53
Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery
Wang, M., Xu, L., Ma, Y., & Gu, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.022 · Cited by 54
Das, P., & Jana, N. R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01667 · Cited by 53
Malatesta, M. (2016) · European Journal of Histochemistry · doi:10.4081/ejh.2016.2751 · Cited by 53
Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect
Bae, Y., Jung, M. K., Lee, S., Song, S. J., Mun, J. Y., Green, E. S., Han, J., Ko, K. S., & Choi, J. S. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.12.013 · Cited by 53
Vermeulen, L. M. P., Brans, T., Smedt, S. C. D., Remaut, K., & Braeckmans, K. (2018) · Nano Today · doi:10.1016/j.nantod.2018.06.007 · Cited by 54
Simonson, A. W., Lawanprasert, A., Goralski, T. D. P., Keiler, K. C., & Medina, S. H. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.10.008 · Cited by 53
Allen, J. K., Najjar, K., Erazo‐Oliveras, A., Kondow-McConaghy, H. M., Brock, D. J., Graham, K. D., Hager, E. C., Marschall, A. L. J., Dübel, S., Juliano, R. L., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00585 · Cited by 56
Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides
Kuhn, J., Lin, Y., Levačić, A. K., Danaf, N. A., Peng, L., Höhn, M., Lamb, D. C., Wagner, E., & Lächelt, U. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00853 · Cited by 54
Kajimoto, K., Sato, Y., Nakamura, T., Yamada, Y., & Harashima, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.058 · Cited by 52
Application of chloroquine as an endosomal escape enhancing agent: new frontiers for an old drug
Hajimolaali, M., Mohammadian, H., Torabi, A., Shirini, A., Shal, M. K., Nezhad, H. B., Iranpour, S., Eftekhari, R. B., & Dorkoosh, F. A. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1873272 · Cited by 56
Jin, M., Hou, Y., Quan, X., Chen, L., Gao, Z., & Huang, W. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s313339 · Cited by 52
Nanozyme‐Based Artificial Organelles: An Emerging Direction for Artificial Organelles
Zhang, S., Zhang, R., Yan, X., & Fan, K. (2022) · Small · doi:10.1002/smll.202202294 · Cited by 52
Shi, Y., Bu, W., Chu, D., Lin, W., Li, K., Huang, X., Wang, X., Wu, Y., Wu, S., Li, D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303206 · Cited by 53
Ming, X., Carver, K. A., FISHER, M. S., Noël, R., Cintrat, J., Gillet, D., Barbier, J., Cao, C., Bauman, J. A., & Juliano, R. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt066 · Cited by 52
Wang, W., Sreekumar, P. G., Valluripalli, V., Shi, P., Wang, J., Lin, Y., Cui, H., Kannan, R., Hinton, D. R., & MacKay, J. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.028 · Cited by 52
Mechanistic Insights into LDL Nanoparticle-Mediated siRNA Delivery
Jin, H., Lovell, J. F., Chen, J., Lin, Q., Ding, L., Ng, K. K., Pandey, R. K., Manoharan, M., Zhang, Z., & Zheng, G. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200233n · Cited by 52
Lin, G., Zhou, J., Cheng, H., & Liu, G. (2023) · Small · doi:10.1002/smll.202207973 · Cited by 52
Praseetha, P. K., Litany, R. I. J., Alharbi, H. M., Khojah, A. A., Akash, S., Bourhia, M., Mengistie, A. A., & Shazly, G. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-75333-0 · Cited by 51
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis
Choi, J.-W., Jung, S.-J., Kasala, D., Hwang, J. K., Hu, J., Bae, Y. H., & Yun, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.005 · Cited by 51
pH-Reversible Cationic RNase A Conjugates for Enhanced Cellular Delivery and Tumor Cell Killing
Liu, X., Zhang, P., He, D., Rödl, W., Preiß, T., Rädler, J. O., Wagner, E., & Lächelt, U. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01289 · Cited by 51
Yang, X., Fan, B., Gao, W., Li, L., Li, T., Sun, J., Peng, X., Li, X., Wang, Z., Wang, B., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161908 · Cited by 52
Mohanpuria, P., Govindaswamy, M., Sidhu, G. S., Singh, S., Kaur, S., & Chhuneja, P. (2021) · Egyptian Journal of Biological Pest Control · doi:10.1186/s41938-020-00345-7 · Cited by 51
Metal–Organic Framework Nanoparticles Power DNAzyme Logic Circuits for Aberrant MicroRNA Imaging
Zhang, J., Fu, H., & Chu, X. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02878 · Cited by 50
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
Kim, Y., Kim, H., Kim, E. H., Jang, H., Jang, Y., Chi, S.-G., Yang, Y., & Kim, S. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061271 · Cited by 50
‘Smart’ nanoparticles as drug delivery systems for applications in tumor therapy
Fang, Z., Wan, L., Chu, L., Zhang, Y., & Wu, J. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1071352 · Cited by 50
Polyplexes based on cationic polymers with strong nucleic acid binding properties
Varkouhi, A. K., Mountrichas, G., Schiffelers, R. M., Lammers, T., Storm, G., Pispas, S., & Hennink, W. E. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.002 · Cited by 50
Self-citationDioctadecyldimethylammonium:Monoolein Nanocarriers for Efficient in Vitro Gene Silencing
Oliveira, A. C., Martens, T., Raemdonck, K., Adati, R. D., Feitosa, E., Botelho, C., Gomes, A. C., Braeckmans, K., & Oliveira, M. E. C. D. R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am500793y · Cited by 50
Nanocarriers as Potential Targeted Drug Delivery for Cancer Therapy
Singhvi, G., Rapalli, V. K., Nagpal, S., Dubey, S. K., & Saha, R. N. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-29207-2_2 · Cited by 50
Zhang, X., Pan, J., Yao, M., Mendes, L. P., Sarısözen, C., Mao, S., & Torchilin, V. P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.019 · Cited by 50
Considerations for the delivery of STING ligands in cancer immunotherapy
Petrovic, M., Borchard, G., & Jordan, O. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.033 · Cited by 51
Yang, Y., Meng, Y., Ye, J., Xia, X., Wang, H., Li, L., Dong, W., Jin, D., & Liu, Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.028 · Cited by 49
RGD peptide-based lipids for targeted mRNA delivery and gene editing applications
Qin, J., Xue, L., Gong, N., Zhang, H., Shepherd, S. J., Haley, R. M., Swingle, K. L., & Mitchell, M. J. (2022) · RSC Advances · doi:10.1039/d2ra02771b · Cited by 54
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
Haque, M. A., Shrestha, A., Mikelis, C. M., & Mattheolabakis, G. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100283 · Cited by 52
Moros, M., Mitchell, S. G., Grazú, V., & de la Fuente, J. M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320220003 · Cited by 49
Acoustic-transfection for genomic manipulation of single-cells using high frequency ultrasound
Yoon, S., Wang, P., Qin, P., Wang, Y., & Shung, K. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-05722-1 · Cited by 49
State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.
Heidarli, E., Dadashzadeh, S., & Haeri, A. (2017) · PubMed Central · Cited by 49
Mimicking Pathogenic Invasion with the Complexes of Au22(SG)18-Engineered Assemblies and Folic Acid
Zhang, C., Zhang, A., Hou, W., Li, T., Wang, K., Zhang, Q., de la Fuente, J. M., Jin, W., & Cui, D. (2018) · ACS Nano · doi:10.1021/acsnano.8b00196 · Cited by 49
Graphene oxide as a 2D platform for complexation and intracellular delivery of siRNA
de Lázaro, I., Vranic, S., Marson, D., Rodrigues, A. F., Buggio, M., Esteban-Arranz, A., Mazza, M., Posocco, P., & Kostarelos, K. (2019) · Nanoscale · doi:10.1039/c9nr02301a · Cited by 49
Wei, W., Sun, J., Guo, X., Chen, X., Wang, R., Qiu, C., Zhang, H., Pang, W.-H., Wang, J., & Zhang, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22781 · Cited by 49
Nucleic acid nanotechnology for cancer treatment
Jin, J., Kim, G., Hwang, J., Han, K. H., Kwak, M., & Lee, P. C.-W. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188377 · Cited by 49
Shape matters: Morphologically biomimetic particles for improved drug delivery
Wang, J., Li, Q., Xue, J., Chen, W., Zhang, R., & Xing, D. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127849 · Cited by 49
Hyaluronic acid-based multifunctional carriers for applications in regenerative medicine: A review
An, C., Li, H., Zhao, Y., Zhang, S., Zhao, Y., Zhang, Y., Yang, J., Zhang, L., Ren, C., Zhang, Y., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123307 · Cited by 49
Recent progress in copolymer-mediated siRNA delivery
Wu, Z.-W., Chien, C., Liu, C., Yan, J., & Lin, S. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.699057 · Cited by 50
Novel endosomolytic peptides for enhancing gene delivery in nanoparticles
Ahmad, A., Ranjan, S. K., Zhang, W., Zou, J., Pyykkö, I. V., & Kinnunen, P. K. J. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.008 · Cited by 49
Zhang, M., Yu, Y., Yu, R., Wan, M., Zhang, R., & Zhao, Y. (2013) · Small · doi:10.1002/smll.201300994 · Cited by 48
Molecular bionics – engineering biomaterials at the molecular level using biological principles
Rodríguez‐Arco, L., Poma, A., Ruiz‐Pérez, L., Scarpa, E., Ngamkham, K., & Battaglia, G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.044 · Cited by 49
Puras, G., Martı́nez, G., Mashal, M., Sesma, J. Z., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Díaz‐Tahoces, A., Avilés‐Trigueros, M., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00422 · Cited by 47
Sardo, C., Farra, R., Licciardi, M., Dapas, B., Scialabba, C., Giammona, G., Grassi, M., Grassi, G., & Cavallaro, G. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.03.021 · Cited by 47
Internalized chitosan nanoparticles persist for long time in cultured cells
Malatesta, M., Grecchi, S., Chiesa, E., Cisterna, B., Costanzo, M., & Zancanaro, C. (2015) · European Journal of Histochemistry · doi:10.4081/ejh.2015.2492 · Cited by 47
Live cell imaging of duplex siRNA intracellular trafficking
Hirsch, M., & Helm, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv307 · Cited by 46
The toxin component of targeted anti‐tumor toxins determines their efficacy increase by saponins
Weng, A., Thakur, M., Beceren‐Braun, F., Bachran, D., Bachran, C., Riese, S. B., Jenett‐Siems, K., Gilabert‐Oriol, R., Melzig, M. F., & Fuchs, H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.004 · Cited by 47
Multi-stage, charge conversional, stimuli-responsive nanogels for therapeutic protein delivery
Zhang, X., Zhang, K., & Haag, R. (2015) · Biomaterials Science · doi:10.1039/c5bm00171d · Cited by 47
Dendron conjugation to graphene oxide using click chemistry for efficient gene delivery
Sarkar, K., Madras, G., & Chatterjee, K. (2015) · RSC Advances · doi:10.1039/c5ra07004j · Cited by 49
Maity, A. R., & Stepensky, D. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00697 · Cited by 47
Repurposing bacterial toxins for intracellular delivery of therapeutic proteins
Beilhartz, G. L., Sugiman‐Marangos, S. N., & Melnyk, R. A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.009 · Cited by 49
Obeid, M. A., Elburi, A. H. A., Young, L., Mullen, A. B., Tate, R. J., & Ferro, V. A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00352 · Cited by 47
Metadata
- Authors
- Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J.
- Affiliations
- Utrecht University (NL)
- University of Groningen (NL)
- Corresponding author
- Haisma, Hidde J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 151
- Issue
- 3
- Pages
- 220-228
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2008028087
- Cited by
- 1,561
- References
- 151
- Citations by year
- 2026: 82 · 2025: 82 · 2024: 90 · 2023: 94 · 2022: 122 · 2021: 100 · 2020: 123 · 2019: 120 · 2018: 137 · 2017: 111 · 2016: 127 · 2015: 116 · 2014: 98 · 2013: 90 · 2012: 51
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- endosomal escape, endocytosis, lysosomal degradation, protein delivery, gene delivery, siRNA delivery, viral fusion, pH buffering, biomimetic peptides, polymers, biologic therapy
- MeSH terms
- Animals, Cytosol, DNA, Drug Carriers, Endocytosis, Humans, Intracellular Membranes, Membrane Fusion, Models, Biological, Proteins, Endosomes, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review